Dr. med. Kristine Heidemeyer

Ausbildung / Kliniktätigkeit

Seit 05/2023

Praxistätigkeit Dermatologie Zentrum, Zürich

Seit 2017

Oberärztin, Inselspital, Universitätsklinik für Dermatologie Bern, Leiterin Ästhetische Dermatologie und Lasermedizin

2022

Forschungsaufenthalt Ospedale San Bortolo di Vicenza, IT

2019

Stellvertretung dermatologische Praxis «die Hautärzte Stieger& Kränzlin» St. Gallen

2017

Facharzttitel FMH für Dermatologie und Venerologie

2012 – 2017

Assistenzärztin, Inselspital, Universitätsklinik für Dermatologie Bern

2014

Promotion zur Dr. med. durch die medizinische Fakultät der Universität Bern

2012 – 2013

Assistenzärztin, Chirurgischer Notfall, Klinik Sonnenhof, Bern, Schweiz

2011 – 2012

Assistenzärztin, Innere Medizin, Bürgerspital Solothurn, Schweiz

2010

Staatsexamen

2004 – 2010

Studium Humanmedizin Universität Fribourg und Bern

Mitgliedschaften

FMH

Verbindung der Schweizer Aerztinnen und Aerzte

ADA, DDG

Arbeitsgemeinschaft dermatologische Angiologie

European Academy of Dermatology and Venerology

SGDV

Schweizerische Gesellschaft für Dermatologie und Venerologie

ESLD

European Society for Lasers and Energy Based Devices

Publikationsliste (Auszug)

1.

Comparison of objectively measured motor behavior with ratings of the motor behavior domain of the Bern Psychopathology Scale (BPS) in schizophrenia.
Bracht T, Heidemeyer K, Koschorke P, Horn H, Razavi N, Wopfner A, Strik W, Walther S.
Psychiatry Res. 2012 Jul 30;198(2):224-9

2.

Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and TherapyFeldmeyer L, Heidemeyer K, Yawalkar N.
Int J Mol Sci. 2016 Jul 27;17(8):1214

3.

Treatment of sporadic port-wine stains: a retrospective review of 17 cases consecutively treated by pulsed sequential dual wavelength 595 and 1064 nm laser. Perruchoud DL, Cazzaniga S, Heidemeyer K, Weber B, Dietrich N, Borradori L, Adatto MA.
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):557-563

4.

Apremilast for treatment of recalcitrant aphthous stomatitis.
Schibler F, Heidemeyer K, Klötgen HW, Keshavamurthy V, Yawalkar N.
JAAD Case Rep. 2017 Aug 30;3(5):410-411.

5.

Linkage between patients‘ characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry. Cazzaniga S, Anzengruber F, Augustin M, Boehncke WH, Borradori L, Conrad C, Cozzio A, Djamei V, French LE, Gilliet M, Häusermann P, Heidemeyer K, Itin P, Kolios AGA, Laffitte E, Maul JT, Mainetti C, Naldi L, Navarini AA, Rustenbach SJ, Simon D, Sorbe C, Streit M, Yawalkar N.
J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2313-2318

6.

Mepolizumab failed to affect bullous pemphigoid: A randomized, placebo-controlled, double-blind phase 2 pilot study
Simon D, Yousefi S, Cazzaniga S, Bürgler C, Radonjic S, Houriet C, Heidemeyer K, Klötgen HW, Kozlowski E, Borradori L, Simon HU.
Allergy. 2020 Mar

7.

Successful Treatment of Iatrogenic Cutaneous Siderosis with Pigment Lasers: A Retrospective Study in 15 Consecutive Patients. Heidemeyer K, Feldmeyer L, Raeber I, Dietrich N, Cazzaniga S, Yawalkar N, Seyed Jafari SM, Borradori L, Adatto M.
Acta Derm Venereol. 2020 May 28

8.

Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine.
Munshi M, Junge A, Gadaldi K, Yawalkar N, Heidemeyer K.
JAAD Case Rep. 2020 May 17;6(7):634-636.

9.

Skin Hyperpigmentation Index Facilitating Quantification of Hyperpigmentation in Clinical Practice. Bossart S, Ramelet AA, Willenberg T, Cazzaniga S, Baumgartner M, Heidemeyer K, Hunger RE, Seyed Jafari SM.
Dermatology. 2021;237(3):486-488.

10.

Impact of progesterone on skin and hair in menopause – a comprehensive review.
Gasser S, Heidemeyer K, von Wolff M, Stute P.
Climacteric. 2021 Jun;24(3):229-235.

11.

Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab.
Emelianov V, Feldmeyer L, Yawalkar N, Heidemeyer K.
Case Rep Dermatol. 2021 Jul 9;13(2):347-351.

12.

New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report. <
Lehmann M, Schorno P, Hunger RE, Heidemeyer K, Feldmeyer L, Yawalkar N.
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e752-e755. doi: 10.1111/jdv.17561. Epub 2021 Aug

17.

Effect of topical application of platelet-rich plasma on chronic venous leg ulcerations.
Bossart S, Seyed Jafari SM, Lehmann M, Jossi-Will A, Sane E, Heidemeyer K, Schorno P, Pelloni L, Rammlmair A, Schlapbach C.
Dermatol Ther. 2022 Feb;

18.

Fuchs Syndrome with Isolated Oral Mucosa Lesions due to Severe Herpes Simplex Cheilitis in a Patient with Idiopathic Thrombocytopenic Purpura.
Eyer GC, Heidemeyer K, Exadaktylos A, Ziaka M.
Eur J Case Rep Intern Med. 2022 Apr 4;

19.

Long-Term Dose Optimization of Adalimumab via Dose Spacing in Patients with Psoriasis.
Benzaquen M, Munshi M, Bossart S, Feldmeyer L, Emelianov V, Yawalkar N, Cazzaniga S, Heidemeyer K.
Bioengineering (Basel). 2022 Aug 13

20.

Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS
Gschwend A, Helbling A, Feldmeyer L, Mani-Weber U, Meincke C, Heidemeyer K, Bossart S, Jörg L.
Allergo J Int. 2022 Aug 23:1-8

21.

New onset of sarcoidosis after COVID-19 infection.
Rabufetti A, Borradori L, Heidemeyer K, Feldmeyer L, Hunger RE, Yawalkar N, Seyed Jafari SM.
J Eur Acad Dermatol Venereol. 2022 Oct

22.

Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S, Daneluzzi C, Cazzaniga S, Ramelet AA, Uthoff H, Seyed Jafari SM, Baumgartner M, Hunger RE, Heidemeyer K, Willenberg T. J Eur Acad Dermatol Venereol. 2023 Feb

23.

Pool Toes: A Case Report.
Munshi M, Borradori L, Yawalkar N, Heidemeyer K.
Case Rep Dermatol. 2023 Feb 3

24.

Prevalence of psoriatic arthritis among patients with psoriasis in Italy.
Cazzaniga S, Heidemeyer K, Dondi L, Ronconi G, Pedrini A, Bellatreccia A, Zhong Y, Naldi L, Martini N. J Eur Acad Dermatol Venereol. 2023 Mar

25.

Randomized Open-Label Trial Comparing Teledermatology vs. Face-to-Face Consultation in the Follow-Up of Patients with Mild-to-Moderate Acne.
Heidemeyer K, Bodle L, Böll S, Bossart S, Jafari SMS, Hunger RE, Cazzaniga S.
Acta Inform Med. 2023 Mar

26.

Canakinumab leads to rapid reduction of neutrophilic inflammation and long-lasting response in Schnitzler syndrome. <
Bossart S, Seyed Jafari SM, Heidemeyer K, Yan K, Feldmeyer L, Borradori L, Yawalkar N.
Front Med (Lausanne). 2023 Mar 15

27.

Variables associated with joint involvement and development of a prediction rule for arthritis in psoriasis patients. An analysis of the Italian PsoReal database.
Heidemeyer K, Cazzaniga S, Dondi L, Ronconi G, Pedrini A, Bellatreccia A, Zhong Y, Martini N, Naldi L J Am Acad Dermatol. 2023 Mar 23:

28.

Adverse events in patients treated with Jak-inhibitors for alopecia areata: a systematic review. Sechi A, Song J, Dell’Antonia M, Heidemeyer K, Piraccini BM, Starace M, Naldi L.
J Eur Acad Dermatol Venereol. 2023 Apr 4.

29.

Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry.
Cazzaniga S, Heidemeyer K, Naldi L; PsoReal study group.
Acta Derm Venereol. 2023 Apr 4